IN DEPTH

Can generics producers tackle complex and specialty drugs?

Decentralised paediatric clinical trials trending up but study execution critical 

CMO Moves: Regulatory catalysts for drug manufacturing- August

Reimbursements

NICE makeover: a new look for the UK's HTAs

UK’s health technology assessments (HTAs) enter a new era following changes at NICE and a growing diversion from EU standards

R&D

No drugs for prions: quelling therapeutic scarcity

Internet of things

Getting smart with digital pills

Do generics producers have what it takes to tackle complex and specialty drugs?

Decentralised paediatric clinical trials trending up but study execution critical

CMO Moves: Regulatory catalysts for drug manufacturing

02/23/2024 22:05:14
  • Home | Technology transformation
  • In this issue
  • Contents
  • SHL Medical Company Insight
  • SHL Medical
  • Datwyler Company Insight
  • Datwyler
  • CSafe Global
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Mimotopes Company Insight
  • Mimotopes
  • Comment
  • Tapping into pharma’s growing opportunities in digital health
  • Covid-19 Omicron boosters will reinvigorate injectables manufacturing
  • Implementation of electronic health records will improve the quality of care
  • Despite benefits, long-acting injectables remain underutilised for schizophrenia
  • FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
  • UK health data collaboration paves the way to study Long Covid symptoms
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • In Depth
  • A makeover for NICE: a new look for HTAs in the UK
  • No drugs for prions: investigating new approaches to alleviate therapeutic scarc
  • Getting smart with digital pills
  • Do generics producers have what it takes to tackle complex and specialty drugs?
  • Decentralised paediatric clinical trials trending up but study execution critica
  • CMO Moves: Regulatory catalysts for drug manufacturing—August
  • Biolife Solutions
  • In Data
  • Healthtech deals decreased significantly in the pharma industry in H1 2022
  • North America is seeing a hiring boom in pharmaceutical industry machine learnin
  • Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
  • Digital media hiring levels in the pharmaceutical industry rose in June 2022
  • Events
  • Next issue
08/22/2022 00:00:00